MAIF Avenir — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical DevicesCambridge, US
David Meek(CEO)inBrian Riley(President & Chief Technical Officer)inJoanne Lager(Chief Medical Officer)inWendy DiCicco(Chief Financial Officer)inAdrian Chaisson(Chief of Staff)inJason Cole(Executive Officer)
Co-investorsARCH Venture PartnersEaston CapitalHercules Capital, Inc.RA CapitalRitual CapitalSanofi Ventures+4 more
Mayday was a productivity software company focused on calendar and time management that emphasized empathy and coordination of shared time demands.
AI & Machine LearningFuture of WorkSaaSWellness & FitnessToronto, CA
Diana Lau(Founder)in
Co-investorsColle Capital PartnersTechstarsPanache Ventures
Mayday automates month-end accounting workflows for finance teams using Xero or QuickBooks, eliminating manual work and errors while providing ERP-level insights.
AI & Machine LearningEnterprise SoftwareFintechSaaS
David(Founder & CEO)Griff(Co-founder)
Co-investorsFlying Fox VenturesVentures TogetherFalak Startups
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















